StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2020 it was -$14.89M.

Annual ebitda

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$14.89M–
FY2019Dec 31, 2019-$21.03M–
FY2018Dec 31, 2018-$3.58M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2020Mar 31, 2020-$4.03M–
Q1 FY2019Mar 31, 2019-$4.92M–

More PDS Biotechnology figures

See a number that looks wrong?